Clinical Trials in Maryland

Showing 22321-22340 of 23,284 trials

A Study to Evaluate the Combination of Pegylated Interferon Alfa Plus Valopicitabine in Patients With Hepatitis C

NCT00118768

This Phase II study is being conducted in treatment-naive patients (no previous antiviral therapy for Hepatitis C infection) with genotype-1 chronic hepatitis C to evaluate the safety and effectiveness of valopicitabine alone and together with Pegylated Interferon (a drug approved by the Food and Drug Administration for the treatment of Hepatitis C infection).

Chronic Hepatitis C

Merck Sharp & Dohme LLC175 participantsStarted Aug 2005

Phoenix, Arizona, United States • San Diego, California, United States • San Mateo, California, United States +16 more locations

COMPLETEDPhase 412 miles

An Open-Label Study of Once-Daily Oral Administration of Esomeprazole 40 mg in Patients With Symptoms of Gastroesophageal Reflux Disease (GERD)

NCT00242736

The purpose of this study is to evaluate whether there is a difference in proportion of patients with resolution of heartburn and other symptoms related to gastroesophageal reflux disease (GERD) after four weeks of treatment with esomeprazole (NEXIUM®) in those subjects with Erosive Esophagitis (EE) and those without EE.

GERD

AstraZeneca350 participantsStarted Oct 2005

Alabaster, Alabama, United States • Mobile, Alabama, United States • Tucson, Arizona, United States +22 more locations

A Study to Evaluate the Combination of Pegylated Interferon Alfa Plus Valopicitabine in Patients With Hepatitis C

An Open-Label Study of Once-Daily Oral Administration of Esomeprazole 40 mg in Patients With Symptoms of Gastroesophageal Reflux Disease (GERD)

Find Trials by Condition in Maryland

Enhancing Empathy in Medical Communication Through Perspective-Taking

Pilot Study to Assess the Efficacy of Botulinum Toxin A Treatments on Pain and Disability in Sub-Acute Low Back Pain

Continuous Positive Airway Pressure (CPAP) Promotion And Prognosis - the Army Sleep Apnea Program (ASAP)

MIRAGE: Multi-Institutional Research in Alzheimer's Genetic Epidemiology

Motor-Point Stimulation for Conditioning the Diaphragm of Patients With Amyotrophic Lateral Sclerosis (ALS)

Genetics of Progressive Multifocal Leukoencephalopathy and Acquired Immunodeficiency Syndrome

ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere

The HIP Impact Protection Program (HIP PRO)

Safety Study of RTL1000 (Recombinant T Cell Receptor Ligand) in Subjects With Multiple Sclerosis

Carmustine in Treating Patients With Recurrent Malignant Glioma

Markers for Breast Cancer

Radiolabeled Monoclonal Antibody in Treating Patients With Glioblastoma Multiforme or Anaplastic Astrocytoma

Lung Cancer Informational Study (LCIS)

CPG 7909 Injection in Non-Small Cell Lung Cancer

Multi-Center Phase II Study to Compare MER-101 20mg Tablets to Intravenous Zometa 4mg in Male Bisphosphonate-Naive, Hormone Refractory Prostate Cancer Patients

Evaluation of 24-Hour Intragastric pH Using Esomeprazole, Lansoprazole, and Pantoprazole in Hispanic Patients With GERD

Safety and Efficacy of Laparoscopic Truncal Vagotomy for the Treatment of Obesity

A Study of SR58611A in the Prevention of Depression Relapse in Patients With Major Depressive Disorder